403 related articles for article (PubMed ID: 24449235)
1. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
2. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
3. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
[TBL] [Abstract][Full Text] [Related]
4. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
[TBL] [Abstract][Full Text] [Related]
5. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.
Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD
J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498
[TBL] [Abstract][Full Text] [Related]
6. Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.
Interrante MK; Segal H; Peshkin BN; Valdimarsdottir HB; Nusbaum R; Similuk M; DeMarco T; Hooker G; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Heinzmann J; Kinney AY; Schwartz MD
JNCI Cancer Spectr; 2017 Sep; 1(1):pkx002. PubMed ID: 31304457
[TBL] [Abstract][Full Text] [Related]
7. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986
[No Abstract] [Full Text] [Related]
8. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
[TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
12. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
14. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Butrick M; Kelly S; Peshkin BN; Luta G; Nusbaum R; Hooker GW; Graves K; Feeley L; Isaacs C; Valdimarsdottir HB; Jandorf L; DeMarco T; Wood M; McKinnon W; Garber J; McCormick SR; Schwartz MD
Genet Med; 2015 Jun; 17(6):467-75. PubMed ID: 25232856
[TBL] [Abstract][Full Text] [Related]
15. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
[TBL] [Abstract][Full Text] [Related]
16. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Quinn VF; Meiser B; Kirk J; Tucker KM; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Cicciarelli L; Crowe K; Bowen MT; Mitchell G
Genet Med; 2017 Apr; 19(4):448-456. PubMed ID: 27684037
[TBL] [Abstract][Full Text] [Related]
17. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
Baumanis L; Evans JP; Callanan N; Susswein LR
J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
[TBL] [Abstract][Full Text] [Related]
18. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
19. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
Tercyak KP; Demarco TA; Mars BD; Peshkin BN
Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Schwartz MD; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill S; Jandorf L; Kelly SP; Heinzmann J; Zidell A; Khoury K
Breast Cancer Res Treat; 2018 Aug; 170(3):517-524. PubMed ID: 29611029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
